Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs.

Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs.

Item
http://www.wikidata.org/entity/Q48605102
Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesisAstragaloside IV inhibits NF- κ B activation and inflammatory gene expression in LPS-treated mice.Astragaloside IV Attenuates Glutamate-Induced Neurotoxicity in PC12 Cells through Raf-MEK-ERK Pathway.Pharmacokinetics and tissue distribution study of Praeruptorin D from Radix peucedani in rats by high-performance liquid chromatography (HPLC)Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway.Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network.Research review on the pharmacological effects of astragaloside IV.Astragaloside IV prevents MPP⁺-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production.Astragaloside IV attenuates the H2O2-induced apoptosis of neuronal cells by inhibiting α-synuclein expression via the p38 MAPK pathway.Neuroprotective effects of astragaloside IV on Parkinson disease models of mice and primary astrocytes.Profiling the metabolism of astragaloside IV by ultra performance liquid chromatography coupled with quadrupole/time-of-flight mass spectrometry.Astragaloside IV inhibited the activity of CYP1A2 in liver microsomes and influenced theophylline pharmacokinetics in rats.Ameliorating the effect of astragaloside IV on learning and memory deficit after chronic cerebral hypoperfusion in rats.Protective effect of astragaloside IV against matrix metalloproteinase-1 expression in ultraviolet-irradiated human dermal fibroblasts.
P2860

Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs.

Item
http://www.wikidata.org/entity/Q48605102
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Preclinical pharmacokinetics a ...... agaloside IV in rats and dogs.
@en
Preclinical pharmacokinetics a ...... agaloside IV in rats and dogs.
@nl
type
label
Preclinical pharmacokinetics a ...... agaloside IV in rats and dogs.
@en
Preclinical pharmacokinetics a ...... agaloside IV in rats and dogs.
@nl
prefLabel
Preclinical pharmacokinetics a ...... agaloside IV in rats and dogs.
@en
Preclinical pharmacokinetics a ...... agaloside IV in rats and dogs.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Preclinical pharmacokinetics a ...... agaloside IV in rats and dogs.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698